(5-BROMOPYRIDIN-3-YL)-MORPHOLIN-4-YL-METHANONE, 97.0%, 1g

Ethyl 2-(2,4,6-trichloropyrimidin-5-yl)acetate, 95.0%, 250mg

2,4-Dinitrophenyl acetate, 98%, 250mg

(S)-2-((tert-Butoxycarbonyl)amino)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoic acid, 95.0%, 5g

2,3-Dihydro-pyrrolo[3,2-c]pyridine-1-carboxylic acid tert-butyl ester, 98+%, 250mg

AM-630>98.0%(HPLC)25mg

6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile, 98%, 50mg

Ethyl 2-(Bromomethyl)acrylate (stabilized with HQ)>97.0%(GC)5g

Tetrazolo[1,5-a]quinoxalin-4(5H)-one, 95%, 500mg

2-Ethoxypropanohydrazidehydrochloride, 95.0%, 25g

3-(m-Tolyl)-1H-pyrazole, 95.0%, 1g

(S)-(Tetrahydrofuran-3-yl)methanol, 95.0%, 250mg

tert-Butyl 3-hydroxy-4-oxopiperidine-1-carboxylate, 95.0%, 1g